{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:26:32Z","timestamp":1792499192899,"version":"4.5.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br Dent J"],"published-print":{"date-parts":[[2024,3,22]]},"DOI":"10.1038\/s41415-024-7139-8","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T11:09:03Z","timestamp":1711105743000},"page":"453-456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Medication-related osteonecrosis of the jaw in a paediatric patient taking denosumab: a case report"],"prefix":"10.1038","volume":"236","author":[{"given":"Dominic","family":"Innes-Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"key":"7139_CR3912","doi-asserted-by":"crossref","unstructured":"Marx R E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61: 1115-1117.","DOI":"10.1016\/S0278-2391(03)00720-1"},{"key":"7139_CR3914","doi-asserted-by":"crossref","unstructured":"Bhatt R, Hibbert S A, Munns C F. The use of bisphosphonates in children: review of the literature and guidelines for dental management. Aust Dent J 2014; 59: 9-19.","DOI":"10.1111\/adj.12140"},{"key":"7139_CR3917","doi-asserted-by":"crossref","unstructured":"Duarte N T, Rech B O, Martins I G, Franco J B, Ortega K L. Can children be affected by bisphosphonate-related osteonecrosis of the jaw? A systematic review. Int J Oral Maxillofac Surg 2020; 49: 183-191.","DOI":"10.1016\/j.ijom.2019.08.004"},{"key":"7139_CR3919","doi-asserted-by":"crossref","unstructured":"Ruggiero S L, Dodson T B, Fantasia J et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw - 2014 update. J Oral Maxillofac Surg 2014; 72: 1938-1956.","DOI":"10.1016\/j.joms.2014.04.031"},{"key":"7139_CR3921","doi-asserted-by":"crossref","unstructured":"Hanley D A, Adachi J D, Bell A, Brown V. Denosumab: mechanism of action and clinical outcomes. Int J Clin Pract 2012; 66: 1139-1146.","DOI":"10.1111\/ijcp.12022"},{"key":"7139_CR3923","doi-asserted-by":"crossref","unstructured":"Christou J, Johnson A R, Hodgson T A. Bisphosphonate-related osteonecrosis of the jaws and its relevance to children - a review. Int J Paediatr Dent 2013; 23: 330-337.","DOI":"10.1111\/ipd.12047"},{"key":"7139_CR3926","doi-asserted-by":"crossref","unstructured":"Fangusaro J, Gururangan S, Jakacki R I et al. Bevacizumab-associated osteonecrosis of the wrist and knee in three paediatric patients with recurrent CNS tumours. J Clin Oncol 2013; 31: 24-27.","DOI":"10.1200\/JCO.2012.43.6733"},{"key":"7139_CR3928","unstructured":"Scottish Dental Clinical Effectiveness Programme. Oral Health Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw. 2017. Available at https:\/\/www.sdcep.org.uk\/media\/m0ko0gng\/sdcep-oral-health-management-of-patients-at-risk-of-mronj-guidance-full.pdf (accessed July 2020)."},{"key":"7139_CR3930","doi-asserted-by":"crossref","unstructured":"De Molon R S, Hsu C, Bezouglaia O et al. Rheumatoid Arthritis Exacerbates the Severity of Osteonecrosis of the Jaws (ONJ) in Mice. A Randomized, Prospective, Controlled Animal Study. J Bone Miner Res 2016; 31: 1596-1607.","DOI":"10.1002\/jbmr.2827"},{"key":"7139_CR3932","doi-asserted-by":"crossref","unstructured":"Kuroshima S, Nakajima K, Sasaki M et al. Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice. Stem Cell Res Ther 2019; 10: 209.","DOI":"10.1186\/s13287-019-1308-8"},{"key":"7139_CR3935","doi-asserted-by":"crossref","unstructured":"Kamoun-Goldrat A, Ginisty D, Le Merrer M. Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta. Eur J Oral Sci 2008; 116: 195-198.","DOI":"10.1111\/j.1600-0722.2008.00529.x"},{"key":"7139_CR3937","doi-asserted-by":"crossref","unstructured":"De Souza Tolentino E, de Castro T F, Michellon F C et al. Adjuvant therapies in the management of medication-related osteonecrosis of the jaws: Systematic review. Head Neck 2019; 41: 4209-4228.","DOI":"10.1002\/hed.25944"}],"container-title":["British Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41415-024-7139-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41415-024-7139-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41415-024-7139-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T11:12:43Z","timestamp":1711105963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41415-024-7139-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,3,22]]}},"alternative-id":["7139"],"URL":"https:\/\/doi.org\/10.1038\/s41415-024-7139-8","relation":{},"ISSN":["0007-0610","1476-5373"],"issn-type":[{"value":"0007-0610","type":"print"},{"value":"1476-5373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]},"assertion":[{"value":"6 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}},{"value":"Written consent to publish was obtained for the publication of this case.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}}]}}